Pfizer Inc. (PFE) - Wutah bathi EPS kuartalan

Pfizer Inc. possesses colossal authority in medicine due to the creation of life-saving vaccines. This reputation supports revenue stability, although reliance on patents forces the company to acquire startups. This quarterly EPS chart clearly confirms these processes, where the parameter value reaches -8.90. Currently, management under Albert Bourla is optimizing expenses to restore investor confidence in the post-pandemic period.

Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan pfizer.com (PFE): kanggo periode 04.07.2022 - 10.11.2026

Rincian analitis perusahaan Pfizer Corp (PFE)

- rega saham lan prakiraan rega para ahli:

Rega saham Pfizer|PFE - Prakiraan gabungan firma investasi

- indikator kapitalisasi pasar:

Kapitalisasi pasar Pfizer Corporation|PFE - Rega Tumbas Perusahaan

- indikator nilai aset resik miturut neraca:

Aset Bersih saben Siji Saham Pfizer|PFE - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku pfizer.com|PFE - Aset Neraca Perusahaan

- data tingkat utang lan likuiditas finansial:

- rincian bathi lan kelipatan pasar:

PFE - Penghasilan resik perusahaan|Bathi sing dikarepake Pfizer Inc.|PFE - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Pfizer Corporation|PFE - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Pfizer Corporation|PFE - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Pfizer|PFE - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan pfizer.com|PFE - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Pfizer Inc.

Analisis umum perusahaan:Pfizer - PFE

This indicator measures the quarterly change in earnings per share, reflecting the business's capitalization rate. The effective combination of in-house substance synthesis and outsourced clinical trials directly impacts this calculation. By analyzing the quarterly shift in earnings per share, an investor can see the actual speed of value generation. Growth in this metric confirms the resilience of the Pfizer Inc. (PFE) operating model, serving as a signal regarding the quality of capital allocation.

Pesaing Pfizer Inc. (PFE)